All Recalls

95,050 total recalls in our database

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Feb 28, 2019 Prescription Drugs Nationwide View Details β†’

Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.

Mar 29, 2019 Prescription Drugs Nationwide View Details β†’

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Feb 28, 2019 Prescription Drugs Nationwide View Details β†’

The kits were prepared with incorrect patient ID labels and may contain incorrect components.

Dec 3, 2018 Implants & Prosthetics Nationwide View Details β†’

Users need to be aware when using these protocols for daily on line plan adaptation that: 1) The images acquired using these protocols do not represent the average position of the anatomy during the respiratory motion cycle. The images are based on data acquired around full expiration. 2) The display of the images in the Elekta Unity Application software does not provide information about the protocol used to acquire the image eg. with or without respiratory triggering. Users must select an appropriate scan protocol that is representative of the respiratory phase used in the reference plan.

Mar 12, 2019 Diagnostic Equipment Nationwide View Details β†’

The target value for uptake is incorrect on the value sheet for an analyzer. The target value for this analyzer is listed as 43.8%U and should be 39.4%U.

Feb 7, 2019 Diagnostic Equipment View Details β†’

COBAS INTEGRAΒΏ 400 plus and cobas c 111 analyzers Additional Extra Wash Cycle Configurations and/or Batch Mode Needed for Specific Tests Due to Carry-over

Dec 14, 2018 Diagnostic Equipment Nationwide View Details β†’